Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator

Journal of Molecular Biology

Volumn 279, Issue 4, 1998, Pages 1001-1011

  Yang, Steve Q ^a   Craik, Charles S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ecotin; Phage display; Protease inhibitor; Protein design; uPA

Indexed keywords

ARGININE; METHIONINE; PLASMINOGEN ACTIVATOR; SERINE PROTEINASE INHIBITOR; TRYPSIN; UROKINASE;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; ENZYME ACTIVE SITE; GENETIC ENGINEERING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE; RAT;

BOVINAE; ESCHERICHIA COLI;

EID: 0032546736     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.1749     Document Type: Article

References (23)

1. Andreasen, P. A., Sottrup-Jensen, L., Kjoller, L., Nykjaer, A., Moestrup, S. K., Petersen, C. M. & Gliemann, J. (1994). Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes. FEBS Letters, 338(3), 239-245.
2. Bass, S., Greene, R. & Wells, J. A. (1990). Hormone phage: an enrichment method for variant proteins with altered binding properties. Proteins: Struct. Funct. Genet. 8(4), 309-314.
3. Chung, C. H., Ives, H. E., Almeda, S. & Goldberg, A. L. (1983). Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases. J. Biol. Chem. 258(18), 11032-11038.
4. Corey, D. R., Shiau, A. K., Yang, Q., Janowski, B. A. & Craik, C. S. (1993). Trypsin display on the surface of bacteriophage. Gene, 128(1), 129-134.
5. Dang, Q. D. & Di Cera, E. (1996). Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases. Proc. Natl Acad. Sci. USA, 93(20), 10653-10656.
6. Fazioli, F. & Blasi, F. (1994). Urokinase-type plasminogen activator and its receptor: new targets for antimestastic therapy? Trends Pharmacol. Sci. 15(1), 25-29.
7. Higaki, J. N., Evnin, L. B. & Craik, C. S. (1989). Introduction of a cysteine protease active site into trypsin. Biochemistry, 28(24), 9256-9263.
8. Jamieson, A. C., Kim, S. H. & Wells, J. A. (1994). In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry, 33(19), 5689-5695.
9. Kunkel, T. A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA, 82(2), 488-492.
10. Markland, W., Ley, A. C. & Ladner, R. C. (1996a). Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin. Biochemistry, 35(24), 8058-8067.
11. Markland, W., Ley, A. C., Lee, S. W. & Ladner, R. C. (1996b). Iterative optimization of high-affinity proteases inhibitors using phage display. 1. Plasmin. Biochemistry, 35(24), 8045-8057.
12. McCafferty, J., Griffiths, A. D., Winter, G. & Chiswell, D. J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains. Nature, 348(6301), 552-554.
13. McCafferty, J., Jackson, R. H. & Chiswell, D. J. (1991). Phage-enzymes: expression and affinity chromatography of functional alkaline phosphatase on the surface of bacteriophage. Protein Eng. 4(8), 955-961.
14. McGrath, M. E., Erpel, T., Browner, M. F. & Fletterick, R. J. (1991). Expression of the protease inhibitor ecotin and its co-crystallization with trypsin. J. Mol. Biol. 222(2), 139-142.
15. Pannekoek, H., van Meijer, M., Schleef, R. R., Loskutoff, D. J. & Barbas, C. d. (1993). Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis. Gene, 128(1), 135-140.
16. Perona, J. J. & Craik, C. S. (1995). Structural basis of substrate specificity in the serine proteases. Protein Sci. 4(3), 337-360.
17. Rebar, E. J. & Pabo, C. O. (1994). Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science, 263(5147), 671-673.
18. Roberts, B. L., Markland, W., Ley, A. C., Kent, R. B., White, D. W., Guterman, S. K. & Ladner, R. C. (1992). Directed evolution of a protein: selection of potent neutrophil elasatase inhibitors displayed on M13 fusion phage. Proc. Natl Acad. Sci. USA, 89(6), 2429-2433.
19. Soumillion, P., Jespers, L., Bouchet, M., Marchand-Brynaert, J., Winter, G. & Fastrez, J. (1994). Selection of beta-lactamase on filamentous bacteriophage by catalytic activity. J. Mol. Biol. 237(4), 415-422.
20. Spraggon, G., Phillips, C., Nowak, U. K., Ponting, C. P., Saunders, D., Dobson, C. M., Stuart, D. I. & Jones, E. Y. (1995). The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure, 3(7), 681-691.
21. Stubbs, M. T. & Bode, W. (1995). The clot thickens: clues provided by thrombin structure (published erratum appears in Trends Biochem. Sci. (1995) March 20(3), 131). Trends Biochem. Sci. 20(1), 23-28.
22. Wang, C. I., Yang, Q. & Craik, C. S. (1995). Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage of ecotin. J. Biol. Chem. 270(20), 12250-12256.
23. Yang, S. Q., Wang, C. I., Gillmor, S. A., Fletterick, R. J. & Craik, C. S. (1998). Ecotin: a serine protease inhibitor with two distinct and interacting binding sites. J. Mol. Biol. 279, 945-957.